ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $69,195 | +15.0% | 1,500 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $60,150 | -13.4% | 1,500 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $69,495 | +12.1% | 1,500 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $62,000 | -30.3% | 1,500 | 0.0% | 0.01% | -33.3% |
Q2 2022 | $89,000 | -18.3% | 1,500 | 0.0% | 0.01% | +28.6% |
Q1 2022 | $109,000 | -13.5% | 1,500 | 0.0% | 0.01% | -12.5% |
Q4 2021 | $126,000 | -6.7% | 1,500 | 0.0% | 0.01% | -11.1% |
Q3 2021 | $135,000 | -5.6% | 1,500 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $143,000 | -16.4% | 1,500 | 0.0% | 0.01% | -25.0% |
Q1 2021 | $171,000 | -17.8% | 1,500 | 0.0% | 0.01% | -29.4% |
Q4 2020 | $208,000 | +69.1% | 1,500 | 0.0% | 0.02% | +54.5% |
Q3 2020 | $123,000 | +5.1% | 1,500 | 0.0% | 0.01% | +22.2% |
Q2 2020 | $117,000 | +74.6% | 1,500 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $67,000 | +4.7% | 1,500 | 0.0% | 0.01% | +20.0% |
Q4 2019 | $64,000 | -47.5% | 1,500 | -47.4% | 0.01% | -54.5% |
Q3 2019 | $122,000 | -32.6% | 2,850 | 0.0% | 0.01% | -45.0% |
Q2 2019 | $181,000 | -8.6% | 2,850 | 0.0% | 0.02% | -16.7% |
Q1 2019 | $198,000 | +59.7% | 2,850 | 0.0% | 0.02% | +41.2% |
Q4 2018 | $124,000 | -26.2% | 2,850 | +29.5% | 0.02% | -19.0% |
Q3 2018 | $168,000 | -0.6% | 2,200 | 0.0% | 0.02% | -8.7% |
Q2 2018 | $169,000 | +50.9% | 2,200 | 0.0% | 0.02% | +53.3% |
Q1 2018 | $112,000 | +9.8% | 2,200 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $102,000 | – | 2,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |